Diabetes Research and Clinical Practice
Volume 81, Issue 1 , Pages 72-78 , July 2008

High-normal blood pressure, impaired glucose regulation and metabolic syndrome have variable impact on central artery stiffness

  • Kunihiko Aizawa

      Affiliations

    • Aging, Rehabilitation & Geriatric Care Research Centre, Lawson Health Research Institute, Parkwood Hospital, London, Ontario N6C 5J1, Canada
    • School of Kinesiology, The University of Western Ontario, London, Ontario N6A 3K7, Canada
    • ,
  • J. Kevin Shoemaker

      Affiliations

    • School of Kinesiology, The University of Western Ontario, London, Ontario N6A 3K7, Canada
    • ,
  • Tom J. Overend

      Affiliations

    • Aging, Rehabilitation & Geriatric Care Research Centre, Lawson Health Research Institute, Parkwood Hospital, London, Ontario N6C 5J1, Canada
    • School of Kinesiology, The University of Western Ontario, London, Ontario N6A 3K7, Canada
    • School of Physical Therapy, The University of Western Ontario, London, Ontario N6G 1H1, Canada
    • ,
  • Robert J. Petrella

      Affiliations

    • Aging, Rehabilitation & Geriatric Care Research Centre, Lawson Health Research Institute, Parkwood Hospital, London, Ontario N6C 5J1, Canada
    • School of Kinesiology, The University of Western Ontario, London, Ontario N6A 3K7, Canada
    • Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada
    • Corresponding Author InformationCorresponding author at: Aging, Rehabilitation & Geriatric Care Research Centre, Parkwood Hospital, Room B3002, 801 Commissioners Road East, London, Ontario N6C 5J1, Canada. Tel.: +1 519 685 4292x42983; fax: +1 519 685 4060.

Received 11 December 2007 ,Accepted 25 February 2008.

References 

  1. Leitchuk M, Cupples LA, Kannel W, Gagnon D, Chobanian A. High normal blood pressure progression to hypertension in the framingham heart study. Hypertension. 1991;17:22–27
  2. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N. Eng. J. Med. 2006;354:1685–1697
  3. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch. Intern. Med. 1993;153:598–615
  4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up report on the diagnosis of diabetes mellitus, Diabetes Care 26 (2003) 3160–3167.
  5. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch. Intern. Med. 2004;164:2147–2155
  6. The DREAM Trial Investigators . Effect of Ramipril on the incidence of diabetes. N. Eng. J. Med. 2006;355:1551–1562
  7. The DREAM Trial Investigators . Effect of rosiglitazoneon the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368:1096–1105
  8. The Canadian Hypertension Education Program . The 2007 Canadian Hypertension Education Program recommendation: the scientific summary—an annual update. Can. J. Cardiol. 2007;23:521–527
  9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356–359
  10. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 2006;119:812–819
  11. Franklin SS. Arterial stiffness and hypertension: a two-way street?. Hypertension. 2005;45:349–351
  12. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  13. Ferreira I, Henry RMA, Twisk JWR, van Mechelen W, Kemper HCG, Stehouwer CDA. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch. Intern. Med. 2005;165:875–882
  14. Li S, Chen W, Srinivasan SR, Berenson GS. Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa Heart Study. Atherosclerosis. 2005;180:349–354
  15. van Popele NM, Westendorp ICD, Bots ML, Reneman RS, Hoeks APG, Hofman A, et al. Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthy non-diabetic middle-aged women. Diabetologia. 2000;43:665–672
  16. Nakanishi N, Suzuki K, Tatara K. Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanese men. Angiology. 2003;54:551–559
  17. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J. Am. Coll. Cardiol. 2004;43:1388–1395
  18. Schillaci G, Pirro M, Vaudo G, Mannarino MR, Savarese G, Pucci G, et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension. 2005;45:1078–1082
  19. Mulè G, Cottone S, Mongiovi R, Cusimano P, Mezzatesta G, Seddio G, et al. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr. Metab. Cardiovasc. Dis. 2006;16:54–59
  20. Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H, et al. Metabolic syndrome is associated with markers od subclinical atherosclerosis in a French population-based sample. Atherosclerosis. 2006;186:345–353
  21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–2752
  22. Mattu GS, Heran BS, Wright JM. Overall accuracy of the BpTRU™—an automated electronic blood pressure device. Blood. Press. Monit. 2004;9:47–52
  23. Laurent S, Caviezel B, Beck L, Girerd X, Billaud E, Boutouyrie P, et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension. 1994;23:878–883
  24. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction: a noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989;80:78–86
  25. O’Rourke MF. Mechanical principles in arterial disease. Hypertension. 1995;26:2–9
  26. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am. J. Med. 2006;119:133–141
  27. Safer ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, et al. Metabolic syndrome and age-related progression of aortic stiffness. J. Am. Coll. Cardiol. 2006;47:72–75
  28. Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell’Oro R, et al. Heart rate as a marker of sympathetic overactivity. J. Hypertens. 1998;16:1635–1639
  29. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in industry. Am. J. Epidemiol. 1999;149:853–862
  30. Palatini P, Julius S. Heart rate and the cardiovascular risk. J. Hypertens. 1997;15:3–17
  31. Sa Cunha R, Pannier B, Benetos A, Siche JP, London GM, Mallion JM, et al. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J. Hypertens. 1997;15:1423–1430
  32. Albaladejo P, Asmer R, Safer M, Benetos A. Association between 24-h ambulatory heart rate and arterial stiffness. J. Hum. Hypertens. 2000;14:137–141
  33. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002;105:1202–1207
  34. Mangoni AA, Mircoli L, Giannatassio C, Ferrari AU, Mancia G. Heart rate-dependence of arterial distensibility in vivo. J. Hypertens. 1996;14:897–901
  35. Giannattasio C, Vincenti A, Failla M, Capra A, Ciro A, De Ceglia S, et al. Effects of heart rate changes on arterial distensibility in humans. Hypertension. 2003;42:253–256
  36. Nichols WW, O’Rourke MF. McDonald's Blood Flow in Arteries: Theoretical Experimental and Clinical Principles. 4th ed.. London, UK: Arnold; 1998;
  37. Benetos A, Huguet F, Albaladejo P, Brisac AM, Pappo M, Safer ME, et al. Role of adrenergic tone in mechanical and functional properties of carotid artery during aging. Am. J. Physiol. 1993;265:H1132–H1138
  38. Barenbrock M, Spieker C, Witta J, Evers S, Hoeks APG, Rahn KH, et al. Reduced distensibility of the common carotid artery in patients treated with ergotamine. Hypertension. 1996;28:115–119
  39. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation. 2002;105:213–217
  40. Schmitt M, Avolio A, Qasem A, McEniery CM, Bultin M, Wilkinson IB, et al. Basal NO locally modulates human iliac artery function in vivo. Hypertension. 2005;46:227–231
  41. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, et al. Ageing and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995;91:1981–1987
  42. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF. Superoxide excess in hypertension and ageing: a common cause of endothelial dysfunction. Hypertension. 2001;37:529–534
  43. Roman MJ, Pini R, Pickering TG, Devereux RB. Non-invasive measurements of arterial compliance in hypertensive compared with normotensive adults. J. Hypertens. 1992;10(Suppl. 6):S115–S118
  44. Bussy C, Boutouyrie P, Lacolley P, Challande P, Laurent S. Intrinsic stiffness of the carotid arterial wall material in essential hypertensives. Hypertension. 2000;35:1049–1054

PII: S0168-8227(08)00095-8

doi: 10.1016/j.diabres.2008.02.012

Diabetes Research and Clinical Practice
Volume 81, Issue 1 , Pages 72-78 , July 2008

Article Tools

* Image Usage & Resolution